Medicus Pharma Ltd. -29MDCXWPreferred / convertible
13F holders, Q2 2025 (June 30)5holders −2
0new positions
2sold out
$1.31avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Medicus Pharma Ltd. -29 (MDCXW) in their 13F filings, down 2 from Q1 2025. 0 opened new positions and 2 sold out. The largest holders were Anson Funds Management LP ($127K), Armistice Capital, LLC ($54K) and Warberg Asset Management LLC ($53K).
- Company
- Medicus Pharma Ltd. -29
- CUSIP
- 58471K111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $48K |
All 13F filers, Q1 2025 → Q2 2025: 24,000 shares bought and 73,430 shares sold, net −49,430 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Anson Funds Management LP | — | No change | 42,400 | $127K |
| Armistice Capital, LLC | — | No change | 60,600 | $54K |
| Warberg Asset Management LLC | — | Reduce -8.3% | 59,611 | $53K |
| Private Advisor Group, LLC | — | Add +160.0% | 39,000 | $34K |
| Connective Capital Management, LLC | — | No change | 6,000 | $5K |
"% of holder's portfolio" is MDCXW's weight in each manager's 13F, not the share of Medicus Pharma Ltd. -29 the manager owns.